vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare ConferenceGlobe Newswire • about 2 months agoHIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an...